Q: Could you advise outlook for the companies/sector. Thank you
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: What is your opinion of Constellation Brands latest results and would the drop today be a good buying opportunity?
Q: I want to put some money in semiconductor stocks. Do you have a company name or ETF that you would recommend? thanks
Q: I am considering taking a position in Nike, using the thesis that its better value to buy a strong company beat up rather than a momentum play. Your opinion gentlemen.
Q: Hi 5i team,
My US portfolio is currently about 9% and consists of GOOG, FB, SBUX, GE, MCD, PM & DEO. I want to buy ETFs to bring the % up to around 20%. In a recent newspaper article about the high valuation of US stocks and possible volatility, the author recommended ZWH and ZPW instead of buying broad base market ETF.
What are your opinions of these two ETFs? Would they be useful tool to reduce risk while still participate in the US stock market if it goes up and also earn some dividends? Which one of the two is more effective or they should be employed as a pair? Many thanks.
My US portfolio is currently about 9% and consists of GOOG, FB, SBUX, GE, MCD, PM & DEO. I want to buy ETFs to bring the % up to around 20%. In a recent newspaper article about the high valuation of US stocks and possible volatility, the author recommended ZWH and ZPW instead of buying broad base market ETF.
What are your opinions of these two ETFs? Would they be useful tool to reduce risk while still participate in the US stock market if it goes up and also earn some dividends? Which one of the two is more effective or they should be employed as a pair? Many thanks.
Q: What do you think of CTL as an income play in a well diversified portfolio, assuming the Level 3 merger goes ahead?
Q: I read your 29 Aug 16 comments on HBI. There SP may have found some level of support. I would appreciate your quick analysis of their fundamentals.
Thanks in advance.
Thanks in advance.
Q: Hi 5i, I've moved some cash over to a US account. Can you suggest 3 or 4 US growth names you would lean towards adding for 2017? I'm looking for pure growth / don't need dividends. Thanks.
Q: How much does Microsoft stand to benefit if the taxation is substantially lowered in respect to the repatriation of money they hold outside of the U.S. ? I've been a subscriber since 2012 and I'm looking forward to another wonderful year with 5i Research. Thank you.
Q: Hello, as a follow up to my questions on us equities; I am simply looking for investment ideas. I would appreciate non financial names and names not Already on my portfolio( 4 of the 6 you provided were equities I already owned ).
If possible, this would be much appreciated,
Thx
KR
If possible, this would be much appreciated,
Thx
KR
-
Amgen Inc. (AMGN)
-
Gilead Sciences Inc. (GILD)
-
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Q: The very best for 2017! May positive trading continue throughout the year!
I would appreciate your input in stock selection, i.e. biotech Amgn vs. Gild, and generics Teva vs. Acorn.
Thank you!
I would appreciate your input in stock selection, i.e. biotech Amgn vs. Gild, and generics Teva vs. Acorn.
Thank you!
Q: Ryan and Peter. Best of the new year to you and the rest of the 5i team. Thanks to Ryan for his article about re-balancing portfolios. I agree that health care is the sector that provides some value. I have some exposure to Canadian health care but would like to buy some exposure to specific American health care companies. If possible, could you suggest a few companies that offer some growth in 2017 and provide a bit of a dividend? Thanks in advance for your appreciated guidance.
Q: Hello, above are the list of us securities i hold. Can you give me your top 5 US conviction names, mid to large cap, preferably not financials as I am already overweight this sector. Your choices do not have to be sector specific. Thank you!
MSFT (Microsoft),CVS (CVS Health),IBB (iShares Nasdaq Biotechnology ETF),AMZN (Amazon Com),RIO (Rio Tinto PLC),PG (Procter and Gamble),LULU (Lululemon Athletica Inc.),DIS (Walt Disney),NFLX (Netflix),DY (Dycom Industries),RTN (Raytheon 'B'),CVX (Chevron),TWX (Time Warner),JPM (JP Morgan Chase and Company),BAC (Bank of America)
KR
MSFT (Microsoft),CVS (CVS Health),IBB (iShares Nasdaq Biotechnology ETF),AMZN (Amazon Com),RIO (Rio Tinto PLC),PG (Procter and Gamble),LULU (Lululemon Athletica Inc.),DIS (Walt Disney),NFLX (Netflix),DY (Dycom Industries),RTN (Raytheon 'B'),CVX (Chevron),TWX (Time Warner),JPM (JP Morgan Chase and Company),BAC (Bank of America)
KR
Q: Hi Peter and Ryan. What are your regarding Gilead (Gild)
Q: I have bought XUS to benefit from stock growth and to hedge against a drop in the Canadian dollar. It has worked on both counts. I am becoming a little more conservative and wonder if there any similar ETFs on the bond side that are available in Canadian dollars but invest in US bonds.
Q: Hope you've had a good holiday season thus far. Just picked up a copy of money sense and noticed they are recommending Owens Corning as a top buy in the US. I did a quick scan on the company and found the following: valuation looks ok, growth has been good but the consensus going forward doesn't look compelling. They have been paying a dividend and buying back stock but I don't see much in terms of driving up the value going forward. What's your view? Is this company a good investment?
Q: Could you please provide a list of the dogs of the Dow for y/e 2016
Q: This is the thesis you offered in early July, on NVDA. It is really about gaming and virtual reality. Its chips have one of the best reputations for speed and quality, both very necessary for these industries. Itis expensive at 25X earnings, but growth should be 40%+ this year. It has $3 billion in cash and generates very strong free cash flow. Revenue growth looks good and it has a solid record (7/8) of beating earnings estimates. It looks like chip applications are widening, as NVDA is also showing good growth from the data centre industry. Autonomous cars are another growing market for the company. It pays a small dividend and we think it is very well managed."
I'm having a very difficult time seeing that anything has changed. If anything, NVDA should be on the cusp of something even better, and yet the Citron thesis says "all the easy money has been made." How can this be? If the easy money has been made, that would suggest that NVDA will be grinding to a halt soon, and yet with the ever-increasing demand for all the areas of technology it covers, I'm at a loss on Citron's approach.
Notwithstanding your usual advice that there are always two-sides to a trade, there still has to be someone who is "more right" ... and I think it's you, and the position you offered in July. Is this still worth a 3 year hold ... my ultimate time frame for this particular account.
Thanks as ever. Happy New Year! ... Thanks for another great year of superlative service!!
I'm having a very difficult time seeing that anything has changed. If anything, NVDA should be on the cusp of something even better, and yet the Citron thesis says "all the easy money has been made." How can this be? If the easy money has been made, that would suggest that NVDA will be grinding to a halt soon, and yet with the ever-increasing demand for all the areas of technology it covers, I'm at a loss on Citron's approach.
Notwithstanding your usual advice that there are always two-sides to a trade, there still has to be someone who is "more right" ... and I think it's you, and the position you offered in July. Is this still worth a 3 year hold ... my ultimate time frame for this particular account.
Thanks as ever. Happy New Year! ... Thanks for another great year of superlative service!!
Q: nhc. is this an ok entry point? is management just ok or very poor. Would the new board members be better than the old ones? the lumpy earnings are not convenient to investors ,with nhc making acquisitions and having their best quarters at certain times of the year. in your opinion do the shorts and or Craig Hellum ($2 target) correct in their (dislike) of the company .thank you!2
Q: Thank you for your excellent service. I wonder if you have any comment or advice regarding the prospects of Bioamber which was recently recommended on Market Call?
Geoff
Geoff